Your browser does not fully support modern features. Please upgrade for a smoother experience.
Subject:
All Disciplines Arts & Humanities Biology & Life Sciences Business & Economics Chemistry & Materials Science Computer Science & Mathematics Engineering Environmental & Earth Sciences Medicine & Pharmacology Physical Sciences Public Health & Healthcare Social Sciences
Sort by:
Most Viewed Latest Alphabetical (A-Z) Alphabetical (Z-A)
Filter:
All Topic Review Biography Peer Reviewed Entry Video Entry
Topic Review
Thyroid Cancer Stem-Like Cells
Thyroid cancer (TC) is the most common endocrine malignancy. Recent progress in thyroid cancer biology revealed a certain degree of intratumoral heterogeneity, highlighting the coexistence of cellular subpopulations with distinct proliferative capacities and differentiation abilities. Among those subpopulations, cancer stem-like cells (CSCs) are hypothesized to drive TC heterogeneity, contributing to its metastatic potential and therapy resistance. CSCs principally exist in tumor areas with specific microenvironmental conditions, the so-called stem cell niches. In particular, in thyroid cancer, CSCs’ survival is enhanced in the hypoxic niche, the immune niche, and some areas with specific extracellular matrix composition.
  • 1.0K
  • 23 Jun 2021
Topic Review
Golgi Dynamics in Cancer Metastasis
The Golgi apparatus is at the center of protein processing and trafficking in normal cells. Under pathological conditions, such as in cancer, aberrant Golgi dynamics alter the tumor microenvironment and the immune landscape, which enhances the invasive and metastatic potential of cancer cells. Among these changes in the Golgi in cancer include altered Golgi orientation and morphology that contribute to atypical Golgi function in protein trafficking, post-translational modification, and exocytosis. Golgi-associated gene mutations are ubiquitous across most cancers and are responsible for modifying Golgi function to become pro-metastatic. The pharmacological targeting of the Golgi or its associated genes has been difficult in the clinic; thus, studying the Golgi and its role in cancer is critical to developing novel therapeutic agents that limit cancer progression and metastasis.
  • 1.0K
  • 31 May 2022
Topic Review
Hypoxia
Hypoxia is a condition commonly observed in the core of solid tumors. The hypoxia-inducible factors (HIF) act as hypoxia sensors that orchestrate a coordinated response increasing the pro-survival and pro-invasive phenotype of cancer cells, and determine a broad metabolic rewiring. These events favor tumor progression and chemoresistance. The increase in glucose and amino acid uptake, glycolytic flux, and lactate production; the alterations in glutamine metabolism, tricarboxylic acid cycle, and oxidative phosphorylation; the high levels of mitochondrial reactive oxygen species; the modulation of both fatty acid synthesis and oxidation are hallmarks of the metabolic rewiring induced by hypoxia.
  • 1.0K
  • 18 Dec 2020
Topic Review
Translational Formulation Technologies for Cancer-Therapy
Over the past few decades, the field of cancer therapy has seen a significant change in the way in which formulations are designed and developed, resulting in more efficient products that allow us to ultimately achieve improved drug bioavailability, efficacy, and safety. However, although many formulations have entered the market, many others have fallen by the wayside leaving the scientific community with several lessons to learn.
  • 1.0K
  • 16 Nov 2020
Topic Review
Zinc and Breast Cancer Survival
Zinc is an essential mineral incorporated into at least 300 enzymes, and is involved in numerous signaling pathways important for, e.g., cell proliferation and differentiation, cell cycle regulation, apoptosis and redox regulation. Zinc has been reported in preclinical studies to trigger an interplay of G protein estrogen receptor with insulin-like growth factor receptor I (IGF-IR) and epidermal growth factor receptor, which results in the activation of important transduction pathways and biological responses such as proliferation and migration in breast cancer cells.
  • 1.0K
  • 04 Jul 2022
Topic Review
Virotherapy against Glioblastoma
Recent advances in understanding of cancer biology have stimulated the development of numerous therapeutic approaches, one of which is virotherapy. Therapy by oncolytic viruses is a promising method for malignant tumors of various histogenesis, both as a monotherapy and as a part of combination therapy.
  • 1.0K
  • 20 Feb 2024
Topic Review
Oncolytic Virus Therapy for PDAC
Pancreatic ductal adenocarcinoma (PDAC) is a devastating malignancy with poor prognosis and a dismal survival rate, expected to become the second leading cause of cancer-related deaths in the United States. Oncolytic virus (OV) is an anticancer approach that utilizes replication-competent viruses to preferentially infect and kill tumor cells. Vesicular stomatitis virus (VSV), one such OV, is already in several phase I clinical trials against different malignancies. VSV-based recombinant viruses are effective OVs against a majority of tested PDAC cell lines. 
  • 1.0K
  • 22 Apr 2021
Topic Review
Liver Transplantation for Perihilar Cholangiocarcinoma
Cholangiocarcinoma (CCA) encompasses all malignant neoplasms arising from the epithelial cells of the biliary tree. About 40% of CCAs are perihilar, involving the bile ducts distal to the second-order biliary branches and proximal to the cystic duct implant. About two-thirds of pCCAs are considered unresectable at the time of diagnosis or exploration. When resective surgery is deemed unfeasible, liver transplantation (LT) could be an effective alternative. The overall survival rates after LT at 1 and 3 years are 91% and 81%, respectively. The overall five-year survival rate after transplantation is 73% (79% for patients with underlying PSC and 63% for de novo pCCA). Multicenter case series reported a 5-year disease-free survival rate of ~65%.
  • 1.0K
  • 30 May 2023
Topic Review
The Gut Microbiome and Colorectal Cancer
Colorectal cancer (CRC) represents a significant global health burden, ranking as the third most common cancer and the second leading cause of cancer-related deaths worldwide. The gut microbiome, composed of trillions of commensal microorganisms, plays a vital role in maintaining homeostasis and overall health. Mounting evidence suggests that alterations in the gut microbiome, referred to as dysbiosis, may contribute to the initiation and progression of CRC by modulating the tumor microenvironment (TME), including the tumor stroma.
  • 1.0K
  • 05 Sep 2023
Topic Review
Cytokine Networks in Brain Metastases
Brain metastases are the most common of all intracranial tumors and a major cause of death in patients with cancer. Cytokines, including chemokines, interferons, interleukins, lymphokines, and tumor necrosis factors are key regulators in the formation of brain metastases. They regulate the infiltration of different cellular subsets into the tumor microenvironment and affect the thera-peutic outcomes in patients.
  • 1.0K
  • 19 Jan 2021
Topic Review
CircRNAs in Human Cancer
In human cancer, circular RNAs (circRNAs) were implicated in the control of oncogenic activities such as tumor cell proliferation, epithelial-mesenchymal transition, invasion, metastasis and chemoresistance. The most widely described mechanism of action of circRNAs is their ability to act as competing endogenous RNAs (ceRNAs) for miRNAs, lncRNAs and mRNAs, thus impacting along their axis, despite the fact that a variety of additional mechanisms of action are emerging, representing an open and expanding field of study.
  • 1.0K
  • 29 Mar 2022
Biography
Silas Palmer Beebe
Silas Palmer Beebe, M.D., PhD (April 22, 1876 – December 6, 1930) an early pioneer in the field of cancer research and the pathology of the disease. Silas Palmer Beebe, also known as S.P. Beebe was born in 1876 in St. Johns, Michigan the son of Aram Beebe, a farmer and justice of the peace and Emma Lucretia (Beebe) Beebe. His father Aram was the son of Paphiras and Lucy (Day) Beebe, of Winh
  • 1.0K
  • 15 Dec 2022
Topic Review
Lynch Syndrome (Hereditary Nonpolyposis Colorectal Cancer)
Lynch syndrome (LS), also known as hereditary nonpolyposis colorectal cancer (HNPCC), is an autosomal dominant genetic disorder associated with an increased lifetime risk of developing colorectal cancer (CRC) (30–73%), endometrial carcinoma (EC) (30–51%) and, less frequently, other malignancies such as gastric, ovarian, urinary tract, pancreatic, small bowel, biliary tract, brain, and skin sebaceous cancers.
  • 1.0K
  • 27 Mar 2023
Topic Review
Breast Cancer Biomarkers From Peripheral Blood Cells
While tissue-specific biomarkers, including immune-cell infiltration of the tumor, atypical cells, changes in tumor gene expression, and other malignant changes can serve as reliable cancer biomarkers, they have certain limitations. For instance, the invasiveness of biopsy acquisition makes tissue-specific biomarkers ill-fitted for the real-time monitoring of treatment response. Additionally, while tumor-infiltrating lymphocytes (TILs) may be powerful prognostic biomarkers and have significant predictive value in identifying patients with the highest likelihood of responding to therapy, they are not useful for the early detection of cancer or for cancer screening in people with no symptoms. Less invasive and more easily accessible methods of biological sample acquisition, such as blood collection, can make early detection more feasible and may increase acceptance among patients, thereby leading to potentially faster diagnosis. Need to focus on circulating blood cell transcriptome as a source of breast cancer (BC) biomarkers.
  • 1.0K
  • 12 Apr 2022
Topic Review
Anticancer Phytochemicals and Their Structure
Cancer is a challenging disease and is the main cause of mortality worldwide; however, its impact is not evenly distributed. The cancer burden in developed and underdeveloped countries has increased over time owing to a variety of factors, including aging and growing populations, rapid socioeconomic growth, and changes in the incidence of risk factors. Since ancient times, plant-based medicines have been employed in clinical practice and have yielded good results. The modern research system and advanced screening techniques for plants’ bioactive constituents have enabled phytochemical discovery for the prevention and treatment of challenging diseases such as cancer. 
  • 1.0K
  • 30 May 2022
Topic Review
Sentinel Node in Oral Cancer
Sentinel lymph node biopsy (SLNB) is a diagnostic staging procedure that aims to identify the first draining lymph node(s) from the primary tumor, the sentinel lymph nodes (SLN), as their histopathological status reflects the histopathological status of the rest of the nodal basin. The routine SLNB procedure consists of peritumoral injections with a technetium-99m [99mTc]-labelled radiotracer followed by lymphoscintigraphy and SPECT-CT imaging. Based on these imaging results, the identified SLNs are marked for surgical extirpation and are subjected to histopathological assessment. The routine SLNB procedure has proven to reliably stage the clinically negative neck in early-stage oral squamous cell carcinoma (OSCC). However, an infamous limitation arises in situations where SLNs are located in close vicinity of the tracer injection site. In these cases, the hotspot of the injection site can hide adjacent SLNs and hamper the discrimination between tracer injection site and SLNs (shine-through phenomenon). Therefore, technical developments are needed to bring the diagnostic accuracy of SLNB for early-stage OSCC to a higher level. 
  • 1.0K
  • 09 Nov 2020
Topic Review
Proanthocyanidins and Anthocyanins in Nicotine-Induced NSCLC Treatment
In traditional medicine, different parts of plants, including fruits, have been used for their anti-inflammatory and anti-oxidative properties. Plant-based foods, such as fruits, seeds and vegetables, are used for therapeutic purposes due to the presence of flavonoid compounds. Proanthocyanidins (PCs) and anthocyanins (ACNs) are the major distributed flavonoid pigments in plants, which have therapeutic potential against certain chronic diseases. PCs and ACNs derived from plant-based foods and/or medicinal plants at different nontoxic concentrations have shown anti-non-small cell lung cancer (NSCLC) activity in vitro/in vivo models through inhibiting proliferation, invasion/migration, metastasis and angiogenesis and by activating apoptosis/autophagy-related mechanisms.
  • 1.0K
  • 02 Aug 2022
Topic Review
Adenocarcinoma of the Colon
Adenocarcinoma of the colon is the most common malignant neoplasia of the gastrointestinal tract and is a major contributor to mortality worldwide. Invasiveness and metastatic behavior are typical of malignant tumors and, because of its portal drainage, the liver is the closest capillary bed available in this case, hence the common site of metastatic dissemination. Current therapies forecast total resection of primary tumor when possible and partial liver resection at advanced stages, along with systemic intravenous therapies consisting of chemotherapeutic agents such as 5-fluorouracil. These cures are definitely not exempt from drawbacks and heavy side effects. Biocompatible polymeric networks, both in colloids and bulk forms, able to absorb large quantities of water and load a variety of molecules-belong to the class of innovative drug delivery systems, thus suitable for the purpose and tunable on each patient can represent a promising alternative. Indeed, the implantation of polymeric scaffolds easy to synthesize can substitute chemotherapy and combination therapies scheduling, shortening side effects. Moreover, they do not require a surgical removal thanks to spontaneous degradation and guarantees an extended and regional cargo release, maintaining high drug concentrations.
  • 1.0K
  • 22 Jan 2021
Topic Review
Androgen Signaling in Prostate Cancer
Key preclinical studies over decades suggest prostate cancer cells titrate androgen signaling to optimize growth. Such laboratory-based studies argue that adaptations that allow growth in a low-androgen environment render prostate cancer sensitive to restoration of androgens, especially at supraphysiologic doses. Based on preclinical data, as well as clinical observations, trials employing high-dose testosterone (HDT) therapy have now been conducted. These trials suggest a clinical benefit in cancer response and quality of life in a subset of castration-resistant prostate cancer patients.
  • 1.0K
  • 18 Sep 2021
Topic Review
The Metastatic Capacity of Melanoma
Metastasization is a multistep process in which cancer cells detach from the primary tumor (or other metastases) and spread to locoregional or distant lymph nodes, or to non-contiguous secondary sites. Here, if the tissue microenvironment allows them to survive, they generate a new tumor.
  • 1.0K
  • 21 Oct 2021
  • Page
  • of
  • 129
Academic Video Service